Alkermes plc. Deferred Tax Liabilities, Net, Noncurrent
Alkermes plc. (ALKS) had Deferred Tax Liabilities, Net, Noncurrent of $161.00 thousand as of 2016-03-31, per its 10-Q filed 2016-04-28.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2016-04-28
- 2016-03-31: Deferred Tax Liabilities, Net, Noncurrent $161.00K.
- 2015-12-31: Deferred Tax Liabilities, Net, Noncurrent $470.00K.
- 2015-09-30: Deferred Tax Liabilities, Net, Noncurrent $6.50M.
- 2015-06-30: Deferred Tax Liabilities, Net, Noncurrent $12.75M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent |
|---|---|
| 2016-03-31 | $161.00K 10-Q · filed 2016-04-28 |
| 2015-12-31 | $470.00K 10-Q · filed 2016-04-28 |
| 2015-09-30 | $6.50M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $12.75M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $16.79M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $18.92M 10-K · filed 2016-02-25 |
| 2014-09-30 | $21.26M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $26.12M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $25.06M 10-Q · filed 2014-04-30 |
| 2013-12-31 | $29.17M 10-K · filed 2015-02-24 |
| 2013-09-30 | $36.01M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $36.40M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $37.60M 10-KT · filed 2014-02-27 |
| 2012-12-31 | $32.93M 10-Q · filed 2013-01-31 |
| 2012-09-30 | $33.57M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $34.20M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $34.51M 10-K · filed 2013-05-23 |
| 2011-12-31 | $48.97M 10-Q · filed 2012-02-02 |
| 2011-09-30 | $49.83M 10-Q · filed 2011-11-03 |
| 2011-03-31 | $0.00 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |